|
2012 Journal Article Glucarpidase for the treatment of life-threatening methotrexate overdoseTuffaha, H. W. and Al Omar, S. (2012). Glucarpidase for the treatment of life-threatening methotrexate overdose. Drugs of Today, 48 (11), 705-711. doi: 10.1358/dot.2012.48.11.1871575 |
|
2012 Journal Article Development and implementation of a method for characterizing clinical pharmacy interventions and medication use in a cancer centerTuffaha, Haitham W and Koopmans, Sara M (2012). Development and implementation of a method for characterizing clinical pharmacy interventions and medication use in a cancer center. Journal of Oncology Pharmacy Practice, 18 (2), 180-185. doi: 10.1177/1078155211416529 |
|
2012 Journal Article Clinical pharmacy services in the outpatient pediatric oncology clinics at a comprehensive cancer centerTuffaha, Haitham W., Abdelhadi, Ola and Al Omar, Suha (2012). Clinical pharmacy services in the outpatient pediatric oncology clinics at a comprehensive cancer center. International Journal of Clinical Pharmacy, 34 (1), 27-31. doi: 10.1007/s11096-011-9600-4 |
|
2011 Journal Article Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicityTuffaha, Haitham W and Al Omar, Suha (2011). Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicity. Journal of Oncology Pharmacy Practice, 17 (2), 136-40. doi: 10.1177/1078155209348720 |
|
2010 Journal Article Successful stem-cell mobilization and transplantation using plerixafor in a patient with a germ cell tumorTuffaha, Haitham and Abdel-Rahman, Fawzi Abdel-Latif (2010). Successful stem-cell mobilization and transplantation using plerixafor in a patient with a germ cell tumor. Hematology/ Oncology and Stem Cell Therapy, 3 (4), 203-205. doi: 10.5144/1658-3876.2010.203 |
|
2008 Journal Article The use and effectiveness of granulocyte colony-stimulating factor in primary prophylaxis for febrile neutropenia in the outpatient settingTuffaha, Haitham W., Treish, Imad M. and Zaru, Luna (2008). The use and effectiveness of granulocyte colony-stimulating factor in primary prophylaxis for febrile neutropenia in the outpatient setting. Journal of Oncology Pharmacy Practice, 14 (3), 131-8. doi: 10.1177/1078155208091249 |
